| |
| |
|
| Insider
Information: |
Aker Hazel M |
| Relationship: |
Legal Counsel |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
4,284 |
|
|
Indirect Shares
|
46,987 |
|
|
| Direct
Value |
$1,468 |
|
|
|
Indirect Value
|
$16,098 |
|
|
| Total
Shares |
51,271 |
|
|
| Total
Value |
$17,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 153.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cadence Pharmaceuticals Inc |
CADX |
SVP, GC & Secretary |
2014-03-19 |
0 |
2008-02-20 |
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Legal Counsel |
2020-07-21 |
4,284 |
2020-07-21 |
46,987 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Legal Counsel |
• – – |
2020-07-21 |
4 |
B |
$2.38 |
$99,998 |
I/I |
41,972 |
46,987 |
1.99 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel |
• – – |
2019-06-07 |
4 |
A |
$0.00 |
$0 |
I/I |
5,015 |
5,015 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel |
• – – |
2019-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,284 |
4,284 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2014-03-19 |
4 |
D |
$14.00 |
$52,430 |
D/D |
(3,745) |
0 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2013-12-16 |
4 |
AS |
$8.76 |
$114,003 |
D/D |
(13,014) |
3,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2013-12-16 |
4 |
OE |
$3.51 |
$45,679 |
D/D |
13,014 |
16,759 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2013-11-15 |
4 |
AS |
$7.00 |
$385,475 |
D/D |
(52,056) |
3,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2013-11-15 |
4 |
OE |
$3.51 |
$182,717 |
D/D |
52,056 |
55,801 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2013-07-22 |
4 |
AS |
$7.81 |
$50,820 |
D/D |
(6,507) |
3,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2013-07-22 |
4 |
OE |
$3.51 |
$22,840 |
D/D |
6,507 |
10,252 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2013-07-15 |
4 |
AS |
$7.34 |
$47,780 |
D/D |
(6,508) |
3,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2013-07-15 |
4 |
OE |
$3.51 |
$22,843 |
D/D |
6,508 |
10,253 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2011-11-21 |
4 |
AS |
$4.16 |
$41,621 |
D/D |
(10,000) |
3,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2011-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
13,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP, GC & Secretary |
• – – |
2008-02-20 |
4 |
A |
$5.34 |
$19,998 |
D/D |
3,745 |
3,745 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
